News
A recent FDA letter to makers and distributors of a decades-old thyroid medication has stoked outrage among a subset of ...
Buying $100 In ABBV: If an investor had bought $100 of ABBV stock 5 years ago, it would be worth $212.70 today based on a price of $204.94 for ABBV at the time of writing.
Avalo Therapeutics (NASDAQ:AVTX) stock rises as Cantor Fitzgerald launches coverage with an Overweight rating, highlighting its lead asset, AVTX-009. Read more here.
What should investors do? One good answer: Buy dividend stocks. Dividends boost total returns and will pay you to wait for a ...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...
President Donald Trump ordered administration officials to draw up a list of 26 key drugs to develop a stockpile in the ...
In addition to Cantor Fitzgerald, AbbVie also received a Buy from Piper Sandler’s David Amsellem in a report issued yesterday. However, on August 4, Bernstein maintained a Hold rating on AbbVie (NYSE: ...
In ancient Celtic folklore, Tír na nÓg is the land of eternal youth, where time stands still and people don’t age. Today, in ...
The vitiligo treatment landscape is evolving with a shift towards targeted therapies, which have shown encouraging results in promoting repigmentatio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results